106 related articles for article (PubMed ID: 38734581)
21. The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast.
van la Parra RF; Ernst MF; Barneveld PC; Broekman JM; Rutten MJ; Bosscha K
Eur J Surg Oncol; 2008 Jun; 34(6):631-5. PubMed ID: 17851019
[TBL] [Abstract][Full Text] [Related]
22. Microinvasive Carcinoma versus Ductal Carcinoma
Kim M; Kim HJ; Chung YR; Kang E; Kim EK; Kim SH; Kim YJ; Kim JH; Kim IA; Park SY
J Breast Cancer; 2018 Jun; 21(2):197-205. PubMed ID: 29963116
[TBL] [Abstract][Full Text] [Related]
23. Ductal carcinoma in situ: is there a role for MRI?
Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
[TBL] [Abstract][Full Text] [Related]
24. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
[TBL] [Abstract][Full Text] [Related]
25. Predicting Upgrade of Ductal Carcinoma In Situ to Invasive Breast Cancer at Surgery With Ultrafast Imaging.
Miceli R; Gao Y; Qian K; Heller SL
AJR Am J Roentgenol; 2023 Jul; 221(1):34-43. PubMed ID: 36752370
[No Abstract] [Full Text] [Related]
26. Prediction of Underestimation Using Contrast-Enhanced Spectral Mammography in Patients Diagnosed as Ductal Carcinoma In Situ on Preoperative Core Biopsy.
Shin HJ; Choi WJ; Park SY; Ahn SH; Son BH; Chung IY; Lee JW; Ko BS; Kim JS; Chae EY; Cha JH; Kim HH
Clin Breast Cancer; 2022 Apr; 22(3):e374-e386. PubMed ID: 34776365
[TBL] [Abstract][Full Text] [Related]
27. An update of sentinel lymph node mapping in patients with ductal carcinoma in situ.
Wilkie C; White L; Dupont E; Cantor A; Cox CE
Am J Surg; 2005 Oct; 190(4):563-6. PubMed ID: 16164920
[TBL] [Abstract][Full Text] [Related]
28. Is Sentinel Lymph Node Biopsy Required for a Core Biopsy Diagnosis of Ductal Carcinoma In Situ with Microinvasion?
Flanagan MR; Stempel M; Brogi E; Morrow M; Cody HS
Ann Surg Oncol; 2019 Sep; 26(9):2738-2746. PubMed ID: 31147995
[TBL] [Abstract][Full Text] [Related]
29. Characteristics, prognosis, risk factors, and management of recently diagnosed ductal carcinoma in situ with microinvasion.
Li C; Yang Y; Wang J; Jin K; Yang Z; Yu X; Guo X; Chen X
Cancer Med; 2021 Oct; 10(20):7203-7212. PubMed ID: 34547183
[TBL] [Abstract][Full Text] [Related]
30. A Nomogram to Predict Factors Associated with Lymph Node Metastasis in Ductal Carcinoma In Situ with Microinvasion.
Gooch JC; Schnabel F; Chun J; Pirraglia E; Troxel AB; Guth A; Shapiro R; Axelrod D; Roses D
Ann Surg Oncol; 2019 Dec; 26(13):4302-4309. PubMed ID: 31529311
[TBL] [Abstract][Full Text] [Related]
31. Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion?
Murphy CD; Jones JL; Javid SH; Michaelson JS; Nolan ME; Lipsitz SR; Specht MC; Lesnikoski BA; Hughes KS; Gadd MA; Smith BL
Am J Surg; 2008 Oct; 196(4):566-8. PubMed ID: 18760400
[TBL] [Abstract][Full Text] [Related]
32. Multiple Microinvasion Foci in Ductal Carcinoma
Si J; Guo R; Pan H; Lu X; Guo Z; Han C; Xue L; Xing D; Wu W; Chen C
Front Oncol; 2020; 10():607502. PubMed ID: 33344258
[TBL] [Abstract][Full Text] [Related]
33. Role of axillary staging in women diagnosed with ductal carcinoma in situ with microinvasion.
Pimiento JM; Lee MC; Esposito NN; Kiluk JV; Khakpour N; Carter WB; Han G; Laronga C
J Oncol Pract; 2011 Sep; 7(5):309-13. PubMed ID: 22211128
[TBL] [Abstract][Full Text] [Related]
34. The Demographic Features, Clinicopathological Characteristics and Cancer-specific Outcomes for Patients with Microinvasive Breast Cancer: A SEER Database Analysis.
Wang W; Zhu W; Du F; Luo Y; Xu B
Sci Rep; 2017 Feb; 7():42045. PubMed ID: 28165014
[TBL] [Abstract][Full Text] [Related]
35. In situ and minimally invasive breast cancer: morphologic and kinetic features on contrast-enhanced MR imaging.
Viehweg P; Lampe D; Buchmann J; Heywang-Köbrunner SH
MAGMA; 2000 Dec; 11(3):129-37. PubMed ID: 11154954
[TBL] [Abstract][Full Text] [Related]
36. Axillary evaluation is not warranted in patients preoperatively diagnosed with ductal carcinoma in situ by core needle biopsy.
Si J; Guo R; Huang N; Xiu B; Zhang Q; Chi W; Wu J
Cancer Med; 2019 Dec; 8(18):7586-7593. PubMed ID: 31660702
[TBL] [Abstract][Full Text] [Related]
37. Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases.
Yang M; Moriya T; Oguma M; De La Cruz C; Endoh M; Ishida T; Hirakawa H; Orita Y; Ohuchi N; Sasano H
Pathol Int; 2003 Jul; 53(7):422-8. PubMed ID: 12828606
[TBL] [Abstract][Full Text] [Related]
38. Positive enhancement integral values in dynamic contrast enhanced magnetic resonance imaging of breast carcinoma: ductal carcinoma in situ vs. invasive ductal carcinoma.
Nadrljanski M; Maksimović R; Plešinac-Karapandžić V; Nikitović M; Marković-Vasiljković B; Milošević Z
Eur J Radiol; 2014 Aug; 83(8):1363-7. PubMed ID: 24894697
[TBL] [Abstract][Full Text] [Related]
39. Differences in pathologic characteristics between ductal carcinoma in situ (DCIS), DCIS with microinvasion and DCIS with invasive ductal carcinoma.
Liu BT; Ding JN; Wang JL; Li ZS; Ding YL; Ma R
Int J Clin Exp Pathol; 2020; 13(5):1066-1072. PubMed ID: 32509080
[TBL] [Abstract][Full Text] [Related]
40. Revisit the practice of lymph node biopsy in patients diagnosed as ductal carcinoma in situ before operation: a retrospective analysis of 682 cases and evaluation of the role of breast MRI.
Lai HW; Chang YL; Chen ST; Chang YJ; Wu WP; Chen DR; Kuo SJ; Liao CY; Wu HK
World J Surg Oncol; 2021 Sep; 19(1):263. PubMed ID: 34470633
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
